Search research articles
Contact Us
Filters
Showing results (61-70 of 383) with videos related to
Page
of 39
Sort By:
Blood
|
August 17, 2004
Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628
Madhav V Dhodapkar, Mohamad A Hussein, Erik Rasmussen, et al.
Annals of the New York Academy of Sciences
|
February 6, 2014
The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
Helmut Greim, Debra A Kaden, Richard A Larson, et al.
Blood
|
May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock, Mei La, Ben Sanford, et al.
Bone Marrow Transplantation
|
May 8, 2020
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
Jennifer H Cooperrider, Noreen Fulton, Andrew S Artz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2005
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805
John C Byrd, Bercedis L Peterson, Janice Gabrilove, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 2, 2011
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review
Denise M Oliansky, Richard A Larson, Daniel Weisdorf, et al.
Leukemia & Lymphoma
|
January 15, 2009
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia
Xavier Poiré, Andrew Artz, Richard A Larson, et al.
Blood Advances
|
June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2011
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review
Denise M Oliansky, Richard A Larson, Daniel Weisdorf, et al.
British Journal of Haematology
|
December 11, 2023
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors
Rafael Madero-Marroquin, Adam S DuVall, Caner Saygin, et al.
Page
of 39
Search research articles
Search
Showing results (61-70 of 383) with videos related to
Sort By:
Page
of 39
Blood
|
August 17, 2004
Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628
Madhav V Dhodapkar, Mohamad A Hussein, Erik Rasmussen, et al.
Annals of the New York Academy of Sciences
|
February 6, 2014
The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
Helmut Greim, Debra A Kaden, Richard A Larson, et al.
Blood
|
May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock, Mei La, Ben Sanford, et al.
Bone Marrow Transplantation
|
May 8, 2020
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome
Jennifer H Cooperrider, Noreen Fulton, Andrew S Artz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2005
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805
John C Byrd, Bercedis L Peterson, Janice Gabrilove, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 2, 2011
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review
Denise M Oliansky, Richard A Larson, Daniel Weisdorf, et al.
Leukemia & Lymphoma
|
January 15, 2009
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia
Xavier Poiré, Andrew Artz, Richard A Larson, et al.
Blood Advances
|
June 8, 2019
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
Jun Yin, Betsy LaPlant, Geoffrey L Uy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2011
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review
Denise M Oliansky, Richard A Larson, Daniel Weisdorf, et al.
British Journal of Haematology
|
December 11, 2023
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors
Rafael Madero-Marroquin, Adam S DuVall, Caner Saygin, et al.
Page
of 39